Risk factors

LENSAR (LNSR) risk factors

Item 1A of every LENSAR, Inc. 10-K on file, and what changed from one year to the next.

Open LNSR in Gloomberb →
  • FY2025 10-K risk factors

    80 risks, 8 new, 2 dropped, 18 reworded since the prior year. Terminated merger with Alcon created substantial legal, financial, and retention risks for the company this year. Federal net operating losses increased to $52.6 million while regulatory disclosures shifted to smaller reporting company status. AI and medical device compliance frameworks expanded significantly.

    Filed Mar 31, 2026
  • FY2024 10-K risk factors

    74 risks. LENSAR faces continuing operating losses with a $143.3 million accumulated deficit as of December 31, 2024.

    Filed Feb 27, 2025